A Study of the Changes in Nutrition Status of Patients with Acute Myeloid Leukemia


About this study

The purpose of this study is to determine best practices for the assessment and timing of nutrition interventions in patients who have Acute Myeloid Leukemia (AML).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adult (≥ 18)
  • Hem 2 service
  • Diagnosis of acute myeloid leukemia (AML)
  • Can understand spoken and written English

Exclusion Criteria 

  • Pediatric patients (<18)
  • Diagnosis other than acute myeloid leukemia (AML)
  • Cannot read and understand English

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Joy Heimgartner, M.S., RDN, LD

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer